Press release
Advance Drug Discovery with Creative Biolabs' High-Throughput Screening Solutions
Creative Biolabs uses advanced innovative technology to accelerate drug discovery and research in target-specific therapy for a wide range of diseases, including cancer, genetic disorders, and infectious diseases.New York, USA - November 25, 2024 - In recent years, the field of RNA therapeutics has emerged as a revolutionary area in biotechnology, offering promising avenues for the treatment of a multitude of diseases, including cancer, genetic disorders, and infectious diseases. Furthermore, as more and more becomes understood about the biology of RNA, its potential for gene therapy becomes obvious, resulting in growing attention by the academic and pharmaceutical sectors. Creative Biolabs has modern services and technologies that assist in the creation of cell therapeutics based on RNA. They focus on high-throughput screening techniques that allow for rapid identification of effective RNA molecules, streamlining the drug discovery process.
Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg
SiRNA technology forms an inseparable section of genetics that enables the silencing of cellular regulation mechanisms. Creative Biolabs provides services and capabilities for siRNA screening [https://www.creative-biolabs.com/gene-therapy/sirna-in-vitro-screening-service.htm], which will help select the best siRNA sequences that will downregulate targeted genes most efficiently.
"High-throughput screening in our facility allows us to discover and confirm effective siRNA-modified targets in a timeous manner," said a scientist from this company. "We assist researchers all over the world to carry out their siRNA-based projects and to achieve results that include screening and functional and kinetic analysis of the chosen targets."
Antisense oligonucleotides (ASOs) can be designed to treat a broad range of genetic diseases. Creative Biolabs assists researchers by providing ASO Screening [https://www.creative-biolabs.com/gene-therapy/aso-in-vitro-screening-service.htm] services that allow them to design suitable ASO sequences for gene expression modulation. Enhanced screening technologies allow the development of AO therapeutics with relative ease, precision and efficacy. From sequence design to acquisition of AO with desired anti-sense activity, their practice provides expertise in all aspects of ASO development.
In addition to RNA-based solutions, Creative Biolabs has wide experience in aptamer design [https://www.creative-biolabs.com/gene-therapy/custom-aptamer-design-service-for-rnai.htm] and provides custom solutions to fit the specific requirements of each project.
"Aptamers are molecular tools that are specially engineered for use in diagnostics, therapeutics, and other areas. Our patented aptamer selection and optimization procedures ensure the discovery of aptamers with excellent affinity and specificity. With our expertise, researchers are in a position to design aptamers that bind selectively to specific types of molecules," emphasized the scientist.
As a trusted partner in therapeutics development, Creative Biolabs is dedicated to offering innovative and tailored solutions for our customers to ensure the effects of their projects. Their mission is to provide strong support to customers' research projects with expertise and cutting-edge development platforms.
Learn more information about services regarding RNA therapeutics research, please visit https://www.creative-biolabs.com/gene-therapy.
About Creative Biolabs
Creative Biolabs is a biotechnology company based in US, focusing on the development of efficient solutions for biomedical studies and drug discovery and development. With the commitment to advancing RNA therapeutics, the company delivers siRNA screening, ASO screening, and aptamer design services to enhance customers' research projects for new therapies.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email [http://www.universalpressrelease.com/?pr=advance-drug-discovery-with-creative-biolabs-highthroughput-screening-solutions]
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com/gene-therapy
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Advance Drug Discovery with Creative Biolabs' High-Throughput Screening Solutions here
News-ID: 3757428 • Views: …
More Releases from Getnews

BatchOutput for Microsoft Word Now Supports macOS 26 Tahoe
Zevrix Solutions announces BatchOutput DOC 2.6.5, a compatibility update to company's output automation tool for Microsoft Word. The only software of its kind for Word users on the Mac market, BatchOutput solves the problem of batch exporting to PDF and printing from Office. The app offers variable output file names, batch processing of Word documents, single page export , PDF security, and other time-saving features. The new version adds support…

Comedian Yurie Collins to MC Japan's Biggest Halloween Festival at Zepp Haneda
The Tokyo Halloween Festival 2025 adds another star to its international lineup with the announcement that actress, comedian, and content creator Yurie Collins will serve as the official MC for this year's event at Zepp Haneda, located inside Haneda Innovation City.
Image: https://www.globalnewslines.com/uploads/2025/10/2be137d411f4c35319057d356f4298ad.jpg
Collins, who has starred in hit series such as Orange is the New Black and Gotham and built a following of over half a million fans through her bilingual…

The Resilience of Matin Miryeganeh: A New Memoir on Family, Culture, Academics, …
This is for anyone who feels like the odds are stacked too high, who believes that survival and success can't coexist. It's proof that, even in the harshest conditions, a meaningful and fulfilled life can still be built.
New York, NY, USA - October 7, 2025 - Deeply personal and unflinching, All Is Well is the memoir of Matin Miryeganeh (Mah-TEEN Meer-yeh-GAH-neh), a senior research scientist who has survived immense trauma-not…

Brian Arteaga: A Global Vision for Justice, Investment, and Lasting Change
Brian Arteaga, a Beverly Hills, California philanthropist, law student, and international real estate investor, has spent over 15 years cultivating a legacy defined by purpose, integrity, and global impact. As he approaches graduation and prepares for the California Bar Exam, Arteaga continues to merge his legal ambitions, entrepreneurial success, and humanitarian efforts into a unified mission of empowerment and sustainable progress.
Philanthropy and Global Service
For more than 15 years, Brian Arteaga…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…